-
Cyclosporin A: A Mechanism-First Assay Guide
2026-08-20
Cyclosporin A and cyclosporine are powerful tools for dissecting cyclophilin, calcineurin-NFAT, mitochondrial, and immune biology. This mechanism-first guide shows how to design interpretable assays while avoiding confounding effects from solubility, transport, uptake, and cytotoxicity.
-
WIP1, p38 MAPK, and Pyroptosis in Septic AKI
2026-08-20
The reference study identifies WIP1/PPM1D as a suppressor of renal tubular pyroptosis in sepsis-associated acute kidney injury, acting in part by restraining p38 MAPK phosphorylation. Its combination of single-cell analysis, human acute tubular injury samples, LPS-injured mice, and HK2 cell experiments provides a mechanistic framework for interpreting WIP1 as a potential regulator of inflammatory kidney damage.
-
Elobixibat Hydrate: A Compartment-First Guide
2026-08-19
Elobixibat hydrate is an ileal bile acid transporter inhibitor whose strongest pharmacological signal may occur in the gut rather than plasma. This guide translates its bile acid, TGR5, GLP-1, and FXR-linked biology into practical assay decisions across constipation, colonoscopy preparation, and metabolic research.
-
JC-1 for Mitochondrial Membrane Potential Assays
2026-08-19
JC-1 converts mitochondrial polarization into a practical red-to-green fluorescence ratio for apoptosis detection, mitochondrial dysfunction research, and cellular bioenergetics studies. This guide connects that assay to ferroptosis-focused pulmonary fibrosis research while emphasizing controls, workflow execution, and interpretation limits.
-
N1-Methyl-Pseudouridine-5'-Triphosphate Workflow
2026-08-18
Build more stable, translation-ready RNA by integrating N1-Methyl-Pseudouridine-5'-Triphosphate into controlled in vitro transcription workflows. The same quality-by-design approach supports reporter assays, mRNA vaccine development, and emerging inhaled RNA strategies for remodeling hostile tumor microenvironments.
-
Smg5–Hnrnpl–Mag Axis in Oligodendrocyte Maturation
2026-08-18
The reference study identifies SMG5-dependent nonsense-mediated mRNA decay as an essential post-transcriptional regulator of oligodendrocyte differentiation and CNS myelination. Its findings connect clearance of aberrant Hnrnpl transcripts with HNRNPL-controlled alternative splicing of Mag and Nfasc, providing a mechanistic framework for understanding how RNA quality control influences myelin development.
-
HDAC Inhibitors Repress NUT Function in NUT Carcinoma
2026-08-17
This study developed a dCAS9-based transcriptional screen to identify compounds that suppress the oncogenic activity of BRD4-NUT in NUT carcinoma. It revealed that structurally distinct HDAC inhibitors can repress megadomain-driven transcription, induce tumor-cell differentiation, and enhance the activity of bromodomain inhibition in xenograft models.
-
A-769662 for Reliable AMPK Assays
2026-08-17
A practical, scenario-based guide to using A-769662 (SKU A3963) in cell viability, proliferation, cytotoxicity, and energy-metabolism workflows. It connects dose selection, DMSO handling, proteasome-related confounding, autophagy interpretation, and evidence-based product selection.
-
PD 173074: A Causal Assay Strategy for PAAD
2026-08-16
PD 173074 is more than a selective FGFR1 probe: it can help test whether computationally prioritized signaling dependencies in pancreatic adenocarcinoma are pharmacologically actionable. This article presents a causal assay framework that separates FGFR biology, VEGFR2 effects, and pyroptosis-related hypotheses.
-
Epidermal Growth Factor: Reliable Cell Assays
2026-08-15
A scenario-driven guide to using Epidermal Growth Factor (EGF), human recombinant (SKU P1008) to standardize proliferation, viability, cytotoxicity, and 3D spheroid workflows. It connects product specifications with dose interpretation, storage, assay controls, and literature-backed experimental design.
-
PYR-41: E1 Inhibitor Mechanism and Applications
2026-08-14
PYR-41 is an inhibitor of Ubiquitin-Activating Enzyme E1 that suppresses ubiquitin transfer at the first step of the ubiquitination cascade. Product data report cellular E1-thioester inhibition, NF-κB pathway effects, and activity in a mouse sepsis inflammation model, while the cited IBDV study provides proteasome-linked antiviral context rather than direct PYR-41 validation.
-
Recombinant Human EGF: Reliable Cell Assays
2026-08-14
A scenario-driven guide to using Epidermal Growth Factor (EGF), human recombinant in proliferation, viability, cytotoxicity, and 3D spheroid workflows. It explains how SKU P1008 supports controlled dosing, assay comparability, and practical reagent selection using product specifications and published protocol evidence.
-
Senescent CAFs Drive Breast Cancer Progression
2026-08-13
Ye and colleagues identify a senescent myofibroblast CAF population that suppresses natural killer cell activity through extracellular matrix remodeling, thereby promoting breast tumor growth. The findings connect stromal senescence with immune escape and support senCAF-directed interventions as a potential form of stromal therapy, while also linking senCAF abundance with recurrence risk in human breast lesions.
-
Batimastat (BB-94): From MMPs to Synapses
2026-08-13
Batimastat (BB-94) is more than a broad-spectrum MMP inhibitor: it is a translational tool for testing how extracellular proteolysis reshapes tissue behavior. This thought-leadership article connects its cancer-research utility with new mechanistic insights into localized BDNF processing during neuromuscular junction development.
-
Indole-3-pyruvic Acid Regulates Auxin Biosynthesis
2026-08-12
The 2022 PNAS study identifies indole-3-pyruvic acid (IPA, termed IPyA in the paper) as a feedback regulator of the tryptophan aminotransferase TAA1. Its kinetic, genetic, and comparative evidence explains how the two-step pathway for indole-3-acetic acid biosynthesis avoids excessive intermediate accumulation and operates across Arabidopsis, rice, and tomato.